Fungal Infections in Immunocompromised Hosts
This book is a printed edition of the Special Issue Fungal Infections in Immunocompromised Hosts that was published in JoF
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Book Chapter |
| Published: |
MDPI - Multidisciplinary Digital Publishing Institute
2019
|
| Subjects: | |
| Online Access: | Get Fullteks DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| LEADER | 03455naaaa2201093uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_48211 | ||
| 005 | 20210211 | ||
| 020 | |a books978-3-03897-717-9 | ||
| 020 | |a 9783038977162 | ||
| 024 | 7 | |a 10.3390/books978-3-03897-717-9 |c doi | |
| 041 | 0 | |a English | |
| 042 | |a dc | ||
| 100 | 1 | |a Kontoyiannis, Dimitrios P. |4 auth | |
| 700 | 1 | |a Slavin, Monica |4 auth | |
| 245 | 1 | 0 | |a Fungal Infections in Immunocompromised Hosts |
| 260 | |b MDPI - Multidisciplinary Digital Publishing Institute |c 2019 | ||
| 300 | |a 1 electronic resource (212 p.) | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a This book is a printed edition of the Special Issue Fungal Infections in Immunocompromised Hosts that was published in JoF | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by-nc-nd/4.0/ |2 cc |4 https://creativecommons.org/licenses/by-nc-nd/4.0/ | ||
| 546 | |a English | ||
| 653 | |a toxicity | ||
| 653 | |a risk assessment | ||
| 653 | |a species complex | ||
| 653 | |a galactomannan | ||
| 653 | |a taxonomy | ||
| 653 | |a Aspergillus PCR | ||
| 653 | |a candidemia | ||
| 653 | |a adaptive immunity | ||
| 653 | |a fungal immunity | ||
| 653 | |a T2 Candida | ||
| 653 | |a anti-fungal agents | ||
| 653 | |a innate immunity | ||
| 653 | |a antifungal stewardship | ||
| 653 | |a Immunotherapy | ||
| 653 | |a Candida meningoencephalitis | ||
| 653 | |a liposomal amphotericin B | ||
| 653 | |a anidulafungin | ||
| 653 | |a liver disease | ||
| 653 | |a invasive mold disease | ||
| 653 | |a T2Candida | ||
| 653 | |a AIDS | ||
| 653 | |a (1?3)-?-d-glucan | ||
| 653 | |a literature review | ||
| 653 | |a yeast | ||
| 653 | |a hepatic impairment | ||
| 653 | |a prediction models | ||
| 653 | |a IRIS | ||
| 653 | |a invasive aspergillosis | ||
| 653 | |a antifungal agent | ||
| 653 | |a TNF inhibitors | ||
| 653 | |a Aspergillus fumigatus | ||
| 653 | |a fungal nomenclature | ||
| 653 | |a micafungin | ||
| 653 | |a non-culture-based diagnostics | ||
| 653 | |a PCR | ||
| 653 | |a paracoccidioidomycosis | ||
| 653 | |a Candida auris | ||
| 653 | |a multidrug resistance | ||
| 653 | |a subcutaneous mycoses | ||
| 653 | |a risk score | ||
| 653 | |a mycoses of implantation | ||
| 653 | |a Sporothrix brasiliensis | ||
| 653 | |a antifungal resistance | ||
| 653 | |a immunocompromised hosts | ||
| 653 | |a Sporothrix schenckii | ||
| 653 | |a Aspergillus | ||
| 653 | |a fungus | ||
| 653 | |a cell therapy | ||
| 653 | |a MALDI-ToF MS | ||
| 653 | |a lateral flow | ||
| 653 | |a phylogenetics | ||
| 653 | |a hematological malignancy | ||
| 653 | |a candidiasis | ||
| 653 | |a antifungal drug | ||
| 653 | |a hematological malignancies | ||
| 653 | |a mycoses | ||
| 653 | |a invasive fungal infections | ||
| 653 | |a lymphoma | ||
| 653 | |a kidney transplant | ||
| 653 | |a immune reconstitution inflammatory syndrome | ||
| 653 | |a mechanisms of antifungal resistance | ||
| 653 | |a fungal infections | ||
| 653 | |a cytokine therapy | ||
| 653 | |a sporotrichosis | ||
| 653 | |a beta-d-glucan | ||
| 653 | |a invasive fungal infection | ||
| 653 | |a HIV | ||
| 653 | |a cat-transmitted sporotrichosis | ||
| 653 | |a aspergillosis | ||
| 653 | |a cancer | ||
| 653 | |a prognostic risk model | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/1195 |7 0 |z Get Fullteks |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/48211 |7 0 |z DOAB: description of the publication |